Medicare Enrolled

Dr. Magali Van Den Bergh, M.D.

Hematology · Fort Myers, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
14543 GLOBAL PKWY STE 110, Fort Myers, FL 33913
2392647026
Registered in NPPES since 2012
NPI: 1568717544 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Van Den Bergh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Van Den Bergh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Van Den Bergh

Dr. Magali Van Den Bergh is a hematology specialist in Fort Myers, FL, with 14 years of NPI registration. Based on federal Medicare data, Dr. Van Den Bergh performed 157,784 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Van Den Bergh received a total of $24,896 from 86 pharmaceutical and/or device companies across 795 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Van Den Bergh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years of NPI registration ▲ Top 33% volume in FL $24,896 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 136601 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
157,784
Medicare services
Top 33% in FL for hematology
Not available
Unique patients (not deduplicated)
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Pembrolizumab injection (Keytruda) 25,200 $43 $137
Azacitidine chemotherapy injection
An injection of the medication azacitidine, measured at 1 mg per unit.
15,900 $0 $4
Anti-nausea injection (aprepitant) 15,470 $1 $5
Iron infusion (Feraheme)
An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis.
15,300 $0 $4
Iron sucrose injection (Venofer)
An injection of iron sucrose used to replenish iron levels in the body.
13,000 $0 $5
Daratumumab injection (Darzalex)
An injection containing daratumumab and hyaluronidase-fihj administered under the skin.
12,780 $38 $110
Filgrastim injection (Zarxio) for white blood cells
An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram.
12,540 $0 $2
Paclitaxel chemotherapy injection 9,490 $0 $2
Denosumab injection (Prolia/Xgeva) 7,800 $18 $51
Epoetin alfa injection (Procrit) for anemia
An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis.
7,080 $6 $23
Immune globulin infusion (Gammagard)
An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg.
3,496 $36 $108
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
3,179 $0 $3
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
2,139 $8 $29
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
1,926 $8 $9
Anti-nausea injection (Aloxi/palonosetron) 1,920 $1 $28
Injection, atropine sulfate, 0.01 mg 1,880 $0 $1
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,130 $98 $339
Injection, leucovorin calcium, per 50 mg 823 $3 $12
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
777 $12 $61
Anti-nausea injection (ondansetron/Zofran) 732 $0 $9
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
634 $103 $378
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
605 $11 $69
Fluorouracil injection, 500 mg
Administration of a 500 mg dose of fluorouracil medication via injection.
548 $2 $7
Carboplatin chemotherapy injection, 50 mg
Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection.
439 $2 $41
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
228 $1 $3
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
226 $49 $189
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
196 $1 $6
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
192 $52 $178
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
164 $23 $79
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
160 $144 $474
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
160 $7 $69
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
155 $58 $206
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
150 $23 $84
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
148 $16 $56
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
133 $10 $42
Normal saline infusion, 1000 cc
Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution.
127 $2 $7
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
121 $18 $59
Automated red blood cell count
An automated laboratory test that measures the number of red blood cells in a blood sample.
92 $4 $10
Intravenous hydration infusion, 31-60 minutes
Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes.
86 $26 $156
IV chemotherapy initiation with community continuation
Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living.
68 $134 $637
Intravenous drug injection
A procedure involving the administration of a medication or substance directly into a vein.
67 $29 $156
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
65 $65 $239
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
63 $126 $453
New patient office visit, complex (60-74 min) 62 $174 $585
Concurrent intravenous infusion
Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given.
56 $16 $56
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
55 $26 $89
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
45 $2 $8
Normal saline infusion, 500 ml
Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution.
39 $1 $7
Intravenous push injection of new drug or substance
A healthcare provider injects a new medication or substance directly into a vein using a push technique.
34 $43 $170
Venipuncture for blood collection
A procedure to draw blood from a vein for medical testing or analysis.
32 $68 $277
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
21 $65 $197
Methylprednisolone injection, up to 40 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg.
21 $3 $11
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
19 $4 $15
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
11 $107 $377
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
13.0% high complexity
83.2% medium
3.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$24,896
Total received (2018-2024)
Avg $3,557/year across 7 years
Top 19% in FL for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
86
Companies
795
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,277
2023
$4,727
2022
$3,117
2021
$9,219
2020
$2,703
2019
$1,517
2018
$336

Payments by company (2024)

Merck Sharp & Dohme LLC
$427
PFIZER INC.
$220
TAIHO ONCOLOGY, INC.
$204
E.R. Squibb & Sons, L.L.C.
$173
Gilead Sciences, Inc.
$161
Takeda Pharmaceuticals U.S.A., Inc.
$148
GENZYME CORPORATION
$138
Novartis Pharmaceuticals Corporation
$135
Incyte Corporation
$127
Daiichi Sankyo Inc.
$122
GlaxoSmithKline, LLC.
$106
ABBVIE INC.
$94
Celgene Corporation
$77
Eisai Inc.
$74
Lilly USA, LLC
$73
Alexion Pharmaceuticals, Inc.
$73
Janssen Biotech, Inc.
$73
Mirati Therapeutics, Inc.
$67
BeiGene USA, Inc.
$66
AstraZeneca Pharmaceuticals LP
$57
SpringWorks Therapeutics, Inc.
$56
ARRAY BIOPHARMA INC
$55
Pharmacosmos Therapeutics Inc.
$53
Genmab U.S., Inc.
$51
Fennec Pharmaceuticals, Inc.
$51
Agios Pharmaceuticals, Inc.
$44
SOBI, INC
$44
Exelixis Inc.
$35
Bayer Healthcare Pharmaceuticals Inc.
$32
TerSera Therapeutics LLC
$31
JAZZ PHARMACEUTICALS INC.
$30
ADC Therapeutics America, Inc.
$28
Genentech USA, Inc.
$20
Astellas Pharma US Inc
$19
PUMA BIOTECHNOLOGY, INC.
$18
MorphoSys, US Inc.
$18
Tempus AI, Inc
$17
Cumberland Pharmaceuticals, Inc.
$17
Karyopharm Therapeutics Inc.
$17
Stemline Therapeutics Inc.
$15
Veracyte, Inc.
$13
Top 3 companies account for 26.0% of 2024 payments
All-time payments by company (2018-2024) ›
MorphoSys, US Inc.
$4,378
JAZZ PHARMACEUTICALS INC.
$2,122
SERVIER PHARMACEUTICALS LLC
$1,680
Seagen Inc.
$1,658
E.R. Squibb & Sons, L.L.C.
$1,311
Merck Sharp & Dohme LLC
$1,021
Adaptive Biotechnologies Corporation
$1,000
PFIZER INC.
$984
Celgene Corporation
$894
BeiGene USA, Inc.
$755
Novartis Pharmaceuticals Corporation
$723
Janssen Biotech, Inc.
$714
Incyte Corporation
$622
Merck Sharp & Dohme Corporation
$472
Lilly USA, LLC
$433
GENZYME CORPORATION
$377
Daiichi Sankyo Inc.
$365
Gilead Sciences, Inc.
$307
Astellas Pharma US Inc
$302
GlaxoSmithKline, LLC.
$271
ARRAY BIOPHARMA INC
$269
Takeda Pharmaceuticals U.S.A., Inc.
$231
TAIHO ONCOLOGY, INC.
$204
Regeneron Healthcare Solutions, Inc.
$200
Exelixis Inc.
$197
Amgen Inc.
$187
Eisai Inc.
$181
Pharmacyclics LLC, An AbbVie Company
$180
AstraZeneca Pharmaceuticals LP
$159
Alexion Pharmaceuticals, Inc.
$148
Genentech USA, Inc.
$126
Bayer HealthCare Pharmaceuticals Inc.
$109
Seattle Genetics, Inc.
$94
ABBVIE INC.
$94
Pharmacosmos Therapeutics Inc.
$87
Mirati Therapeutics, Inc.
$86
Spectrum Pharmaceuticals Inc.
$84
Boehringer Ingelheim Pharmaceuticals, Inc.
$78
EMD Serono, Inc.
$75
Genmab U.S., Inc.
$74
Bayer Healthcare Pharmaceuticals Inc.
$71
Alnylam Pharmaceuticals Inc.
$67
Kite Pharma, Inc.
$67
GE HEALTHCARE
$65
EISAI INC.
$65
SOBI, INC
$62
Rigel Pharmaceuticals, Inc.
$59
PharmaEssentia USA Corporation
$59
ADC Therapeutics America, Inc.
$57
SpringWorks Therapeutics, Inc.
$56
Sobi, Inc
$51
Fennec Pharmaceuticals, Inc.
$51
Deciphera Pharmaceuticals Inc.
$50
CTI BioPharma Corp.
$49
Foundation Medicine, Inc.
$48
NanoString Technologies, Inc.
$48
Helsinn Therapeutics (U.S.), Inc.
$47
PUMA BIOTECHNOLOGY, INC.
$45
Sun Pharmaceutical Industries Inc.
$45
Agios Pharmaceuticals, Inc.
$44
Puma Biotechnology, Inc.
$40
Stemline Therapeutics Inc.
$33
Karyopharm Therapeutics Inc.
$31
TerSera Therapeutics LLC
$31
Acrotech Biopharma LLC
$30
Myovant Sciences Inc.
$29
Jazz Pharmaceuticals Inc.
$29
Clinigen Inc
$26
AbbVie, Inc.
$24
Novo Nordisk Inc
$21
Aurobindo Pharma USA, Inc.
$19
Clovis Oncology, Inc.
$19
Epizyme, Inc.,
$19
Ipsen Biopharmaceuticals, Inc
$18
Tempus AI, Inc
$17
Cumberland Pharmaceuticals, Inc.
$17
TESARO, Inc.
$16
GE HealthCare
$16
Tactile Systems Technology Inc
$16
Medtronic, Inc.
$16
Sumitomo Pharma America, Inc.
$14
Dendreon Pharmaceuticals LLC
$14
Dova Pharmaceuticals
$14
Veracyte, Inc.
$13
Sirtex Medical Inc
$12
Heron Therapeutics, Inc.
$10
Top 3 companies account for 32.9% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · Alecensa · Aliqopa · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · ERLEADA · Enhertu · Epkinly · Erleada · Esperoct · FOUNDATIONONE · FRUZAQLA · Fabhalta · Flexitouch Plus · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OSTEOCOOL RF ABLATION · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Pedmark · Phesgo · Pomalyst · Proleukin · Prolia · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · Sustol · TABRECTA · TASIGNA · TAZVERIK · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VYXEOS · Venclexta · Vonjo · Vyloy · XALKORI · XPOVIO · XTANDI · Xtandi · YONSA · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology specialist in Fort Myers?
Compare hematologists in the Fort Myers area by procedure volume, costs, and industry payment transparency.
Browse hematologists nearby

Geographic Context

Hematologists in nearby ZIP areas
17
County median income
$73,099
Nearest hospital to ZIP centroid (approximate)
GULF COAST MEDICAL CENTER LEE HEALTH
8.1 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Van Den Bergh is a mixed practice specialist, with moderate Medicare volume.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Van Den Bergh experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Van Den Bergh performed 25,200 pembrolizumab injection (keytruda) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Van Den Bergh receive payments from pharmaceutical companies?
Yes. Dr. Van Den Bergh received a total of $24,896 from 86 companies across 795 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Van Den Bergh's costs compare to other hematologists in Fort Myers?
Dr. Van Den Bergh's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Van Den Bergh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →